Avata Biosciences
London, United Kingdom· Est.
Avata Biosciences is Developing Next-Generation Medicines for Patients with Epilepsy and Other Neurological Diseases
Private Company
Total funding raised: $10.8M
About
Avata Biosciences is Developing Next-Generation Medicines for Patients with Epilepsy and Other Neurological Diseases
NeuroscienceRare Disease
Funding History
1Total raised:$10.8M
Seed$10.8M